News about us

March 2025

March 2025: QMB Welcomes Bob Bennett to its Advisory Board

Boston, MA – QMB (Quality Means Business) is pleased to announce the addition of Bob Bennett to its esteemed advisory board. With over 35 years of experience leading and scaling businesses to extraordinary success, Bob will provide strategic guidance and insights as QMB continues to expand its impact in the business world.

Bob has played a pivotal role in founding and leading multiple high-growth companies, including MicroFridge, InvoiceCloud, and EngageSmart. As the driving force behind EngageSmart, he led the company from inception to IPO and later to a $4 billion acquisition by Vista Equity Partners in January 2024. His expertise in sales-driven strategy, operational excellence, and sustainable growth has consistently delivered impressive results across various industries.

“Bob’s experience and leadership in building businesses from the ground up and scaling them to success make him an invaluable addition to QMB,” said Michel Moravia, CEO at QMB. “His expertise in creating systems for long-term profitability aligns perfectly with our mission to help businesses achieve sustainable success.”

Bob’s career is defined by his ability to identify market opportunities, implement scalable playbooks, and build high-performing teams. His approach to leadership emphasizes strategic execution, growth mindset, and continuous innovation, making him a powerful addition to QMB’s advisory board.

“I’m excited to join QMB and contribute to a mission that resonates deeply with my own beliefs,” said Bob Bennett. “Quality in business isn’t just about products or services—it’s about creating systems that drive sustainable, profitable growth, and I look forward to helping QMB and its community achieve that.”

For more information about QMB and its advisory board, visit https://qmbdevices.com

February 2025

February 2025: Stephanie Shaw, PhD to join the QMB / QualiVerse® Advisory Board.

QMB welcomes Stephanie Shaw to help with the continued development of novel solutions for the life sciences regulatory industry.

“Dr Shaw brings a tremendous amount of experience to her advisory role. She will be instrumental in helping us continue to broaden our RA and QA knowledge base for further implementation into our unique software solutions…”

Stephanie Shaw is a seasoned regulatory affairs professional with over 26 years of experience in the medical device and pharmaceutical industries. With a background that spans organizations of all sizes, she has held executive leadership roles and brings diverse expertise in R&D, regulatory compliance (GMP, QMSR, MDSAP, MDR, and warning letter clearance), and regulatory affairs for Class I, II, III medical devices, and pharmaceuticals. Stephanie is adept at crafting and executing innovative global regulatory strategies, achieving success in streamline entry to global markets.

As a trusted advisor, Stephanie guided multiple organizations through complex regulatory challenges while shaping strategic decisions in a rapidly evolving global landscape. Stephanie holds a Ph.D. in Organic Chemistry from UC Riverside.

May 2024

QMB welcomes Dale Jones to their organization. Boston, MA, USA – May 5, 2024 – QMB, Inc. a leading Quality and Regulatory consulting firm and Tech Startup developing a disruptive AI-enabled Regulatory SaaS platform called QualiVerseä, welcomes Dale Jones as Principal Consultant.

“Dale adds a tremendous amount of additional experience to the QMB consulting team. His background in quality and working for a wide range of organizations makes him a great versatile asset for all current and future clients of QMB.”

Mr. Dale Jones has a been working within the Quality Management sector for nearly seventeen years. He has held numerous quality focused roles within companies such as Thermo Fisher Scientific, Amazon Global Robotics, and Materion Corporation and has consulted with others such as Johnson & Johnson, Philips Healthcare, and LumiraDx. Dale is CMQ/OE certified, and additionally holds certifications in ISO 9001/13485. Dale obtained a BSc in Microbiology from University of Wisconsin-Oshkosh and a MSc in Bacteriology from University of WisconsinMadison.

April 2024

Michel Moravia will be leading a regulatory workshop on February 27th at Evolve, a Northeastern University Accelerator focused on working with early-stage life science and healthcare ventures. “QMB understands the effort and dedication required to make startup ventures successful. We see such opportunities as a new way to reach out and collaborate with a new generation of innovators and disruptors in life sciences. We want to help them with their regulatory strategy and provide guidance so that they succeed…”

April 10, 2024, Michel Moravia will be participating in a panel discussion on AI and its effect on biomedical regulation and policy at Harvard Law School

Michel Moravia leads the Northeastern University Evolve startups in a discussion about regulatory standards and quality

February 2024

QMB announces the appointment of John Brzezenski to its QMB QualiVerse Advisory Board Boston, MA, USA – February 11, 2024

QMB, Inc., a tech startup developing an AI SaaS in the MedTech Regulatory sector, today announced that John Brzezinski had joined its strategic Advisory Board as it accelerates the development of its AI regulatory software platform QualiVerse.

“John brings with him an extensive professional and VC network and has great functional/operational experience, allowing him to understand the requirements of getting a startup running and succeeding! We look forward to working with him closely as we continue our development efforts on QualiVerse & AI integration…”

Mr. Brzezenski has a lengthy history of consulting and working in the venture capital investment sector with a special focus on young emerging companies. Additionally, he has a broad-based background spanning operating/executive management, advisory, and private equity roles, helping numerous companies develop and execute successful growth strategies. Mr. Brzezenski has developed perspectives from “all sides of the table,” has been a Partner with a Strategy/Mergers and acquisitions advisory firm, a senior operating executive, and a member of the investment committee of a venture capital firm. Mr. Brzezenski is currently a Partner with J. Locke & Co., a merchant banking group, and a member and former Board Director of Launchpad Venture Group. Mr. Brzezenski graduated with honors from Harvard University with an BA in Economics and holds an MBA from the Kellogg School at Northwestern University.

Michel Moravia will be leading a session and panel at this year’s LSI Emerging MedTech Summit, LSI USA24. This meeEng brings together thought leaders and organizaEons in the world of Medical Device focused on delivering and innovaEng within the healthcare environment. A unique objecEve of this meeEng is to promote collaboraEon and partnering within the industry.